2nd TCR-based Therapies Summit
Evvnt Promotion / evvnt
Archivio
08.06.2021 - 10.06.2021 Virtual
Time: 09:30 to 16:15
Temi della conferenza
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/730790-2?pid=4832
Mr. Customer Service
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
